Minnesota SF 5329: Prescription drugs price increases and reporting requirements provisions

Status: Referred to Health and Human Services (as of 2024-04-04)

State: Minnesota · Session: 2023-2024 · Bill: SF 5329

Subjects: Commerce and Commerce Department, Drugs and Medicine, Health and Health Department

Sponsors: Morrison

View Minnesota SF 5329 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.